LJUBLJANA, July 7 (Reuters) - Slovenia's generic drugs
producer Krka KRKG.LJ KRK.WA said on Thursday its group
sales rose by 1 percent to 603.8 million euros ($668.53
million) in the first half of 2016.
It said sales in its South-East Europe region - Croatia,
Romania, Serbia, Bosnia, Macedonia and Bulgaria - rose by 27
percent while sales in its East Europe region - Russia, Ukraine
and Kazakhstan - fell by 6 percent.
Krka is due to announce half-year profit on July 28.
($1 = 0.9032 euros)
(Reporting By Marja Novak; Editing by Alexandra Hudson)
((Marja.Novak@thomsonreuters.com; +386-1-5058805; Reuters
Messaging: marja.novak.thomsonreuters.com@reuters.net))
Keywords: SLOVENIA KRKA/